Physician profile
Leslie P Stone
NPI 1003916529
$1,531.22
in general payments reported to CMS, 2019-2025
19 companies · $304 in 2025
The $304 reported for 2025 was more than what 85% of Women'S Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $403 · 2023: $420 · 2024: $181 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $367.37 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $264.00 | 2023 | Myrisk |
| Millicent US INC | $136.38 | 2024-2025 | Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $119.49 | 2021-2025 | |
| Hologic Sales and Service, LLC | $110.94 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Sage Therapeutics, LLC | $83.30 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $81.92 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $66.57 | 2022-2024 | Slynd |
| Agile Therapeutics, INC. | $64.77 | 2021-2022 | |
| Myovant Sciences INC. | $37.74 | 2022 | |
| Pfizer INC. | $37.23 | 2025 | |
| Therapeuticsmd, INC. | $29.50 | 2022 | |
| Daiichi Sankyo INC. | $23.75 | 2024 | Injectafer |
| Novo Nordisk INC | $21.45 | 2025 | Wegovy |
| Organon LLC | $19.21 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $19.13 | 2025 | Iqirvo |
| Merck Sharp & Dohme LLC | $18.58 | 2022 | |
| Sumitomo Pharma America, INC. | $16.68 | 2023 | Gemtesa |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.